Participated · Seed · Jun 2026

Joyvié Health has developed continence underwear designed to contain stool in a disposable pouch immediately after excretion, which the company says significantly reduces stool-to-skin contact and speeds changes. Early testing reported approximately a 90% reduction in stool-to-skin contact and roughly 70% faster change times. The company frames its product as addressing faecal incontinence, a condition estimated to affect 656 million people globally and often linked to cancer, dementia, MS, Parkinson’s, spinal injury or ageing. Joyvié was founded by Zoe Robson after a family caregiving experience in 2025 and intends to run pilots across care homes, hospitals and domiciliary settings to collect clinical and health-economics data. Planned near-term activities include a direct-to-consumer launch later this year, publishing white papers, forming strategic partnerships and making first hires. The company also highlights disparities in funding for women’s health and female founders as part of its market-context narrative.

Participated · Seed · Dec 2025

Punto Health is developing a dementia care platform that combines speech-based digital biomarkers with personalized daily care plans and clinician dashboards to shift cognitive care toward earlier identification and proactive, day-to-day support. The system forms a connected ecosystem that guides patients and carers while streamlining monitoring and care coordination for clinicians. Over the past year, the team co-designed and clinically validated the product with partners such as Ace Alzheimer Center Barcelona, several NHS Foundation Trusts, and multiple Spanish hospitals, reaching more than 2,000 individuals in the process. Feedback from these patients, carers, and clinicians has shaped product features aimed at usability and continuous engagement. With fresh seed capital, the company plans to scale its technology, expand hiring in London and Barcelona, and widen access to proactive dementia care for additional families. Financially, Punto Health has secured $2.7 million to fund these growth initiatives. The company is led by co-founder and CEO Anna Muñoz Farré.

Participated · Seed · Sep 2025

BoobyBiome is a London-based biotechnology company focused on the science of breast milk and the microbiome. Founded in 2019 by Dr Lydia Mapstone, Dr Sioned Jones and Dr Tara O’Driscoll, its work builds on over five years of research at the UCL Great Ormond Street Institute of Child Health. The company has created the world’s largest high-resolution breast milk microbiome database and a biobank of proprietary strains that capture beneficial bacterial diversity in human milk. It has developed a patented storage device compatible with any storage bottle that preserves the natural microbiome, antioxidants and vitamins while preventing contamination. BoobyBiome is also developing a live microbiome drop composed of bacteria isolated from breast milk to support the developing microbiomes of formula-fed, C-section, or preterm infants. The company recently raised £2.5m in seed funding to commercialize the storage device, continue R&D on the live drop, expand its commercial team and scale internationally.